Canada Gives Samsung Bioepis A Further Ranibizumab Approval

Health Canada Nod For Byooviz Lucentis Rival Follows US And EU

 
• By David Wallace
  
Canada flag eye
Samsung Bioepis has the first Canadian approval for the ophthalmic biosimilar • Source: Bo Valentino / Alamy Stock Photo
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products